Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection-Reference-Cited by-同舟云学术

Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection

Published:2016-08 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Agrawal Anurodh Shankar,Ying Tianlei,Tao Xinrong,Garron Tania,Algaissi Abdullah,Wang Yanping,Wang Lili,Peng Bi-Hung,Jiang Shibo,Dimitrov Dimiter S.,Tseng Chien-Te K.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep31629.pdf

Reference46 articles.

1. Chan, J. F. et al. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J Infect 65, 477–489, doi: 10.1016/j.jinf.2012.10.002 (2012).

2. Assiri, A. et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 369, 407–416, doi: 10.1056/NEJMoa1306742 (2013).

3. Memish, Z. A. et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis 19, 1819–1823, doi: 10.3201/eid1911.131172 (2013).

4. Cotten, M. et al. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet 382, 1993–2002, doi: 10.1016/S0140-6736(13)61887-5 (2013).

5. Lau, S. K. et al. Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. J Virol 87, 8638–8650, doi: 10.1128/JVI.01055-13 (2013).

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective Efficacy of Novel Engineered Human ACE2-Fc Fusion Protein Against Pan-SARS-CoV-2 Infection In Vitro and in Vivo;Journal of Medicinal Chemistry;2023-12-15

2. Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections;Biomedicines;2022-08-02

3. Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays;Viruses;2021-12-31

4. Discovery of highly potent pancoronavirus fusion inhibitors that also effectively inhibit COVID-19 variants from the UK (Alpha), South Africa (Beta), and India (Delta);2021-09-03

5. Discovery of Antivirals Using Phage Display;Viruses;2021-06-10